Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Nervous System
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Structures of the endophytic microbiota during heart rot development in <i>Abies georgei</i> var. <i>smithii</i>.
High <i>Yersinia</i> prevalence in tonsils of wild boars hunted in Northeast Germany using a novel protocol including long cold enrichment.
Genetic variation, recombinant characteristics, and seroprevalence analysis of echovirus 3 causing severe and mild cases of hand, foot, and mouth disease in Guizhou Province.
Mycelial morphology influenced aerobic DNRA in <i>Streptomyces mediolani</i> EM-B2: short rod-shaped mycelium showed markedly greater efficiency than long filamentous mycelium.
Performance and practicality of 16S nanopore sequencing for routine bacterial identification in clinical samples.
Related Experiment Video
Updated: Mar 6, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Central Nervous System Tuberculosis.
1Department of Medicine-Infectious Disease, Vanderbilt University Medical Center, Nashville, TN 37232.
Central nervous system tuberculosis (CNS-TB) is a severe meningitis that requires prompt diagnosis and treatment. Early intervention with a four-drug regimen and corticosteroids improves outcomes for this serious infection.
More Related Videos
Area of Science:
- Neurology
- Infectious Diseases
- Microbiology
Background:
- Central nervous system tuberculosis (CNS-TB) presents in three forms: meningitis (TBM), intracranial tuberculoma, and spinal arachnoiditis.
- TBM is a subacute to chronic meningitis syndrome characterized by progressive neurological decline, often fatal if untreated.
Purpose of the Study:
- To outline the clinical presentation, diagnostic approaches, and management strategies for CNS-TB.
- To emphasize the importance of early diagnosis and treatment for improving patient outcomes.
Main Methods:
- Diagnosis relies on clinical suspicion, cerebrospinal fluid (CSF) analysis (smear, culture, PCR), and neuroimaging (CT, MRI).
- Characteristic CSF findings include lymphocytic pleocytosis, low glucose, and high protein levels.
- Neuroimaging may reveal meningeal enhancement and hydrocephalus, suggestive of TBM.
Main Results:
- TBM commonly involves vasculitis leading to infarcts, a major cause of morbidity and mortality.
- Early treatment initiation is crucial for effectiveness.
- A four-drug regimen (isoniazid, rifampin, pyrazinamide, ethambutol) is recommended to cover resistant strains and prevent resistance.
- Adjunctive corticosteroids reduce morbidity and mortality in most cases.
Conclusions:
- Prompt diagnosis and treatment of CNS-TB, particularly TBM, are critical.
- A combination of anti-tuberculosis drugs and corticosteroids offers the best therapeutic approach.
- Early intervention significantly impacts patient outcomes and reduces mortality.

